American International Group, Inc. Ultragenyx Pharmaceutical Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$43.02 - $53.69 $774 - $966	-18 Reduced 1.35%	1,311 $61,000
Q4 2023 Feb 13, 2024	BUY	$31.73 - $49.19 $4,886 - $7,575	154 Added 13.11%	1,329 $63,000
Q3 2023 Nov 13, 2023	SELL	$34.92 - $46.66 $2,863 - $3,826	-82 Reduced 6.52%	1,175 $41,000
Q2 2023 Aug 04, 2023	BUY	$37.35 - $52.15 $12,512 - $17,470	335 Added 36.33%	1,257 $57,000
Q1 2023 May 12, 2023	SELL	$36.99 - $48.71 $998 - $1,315	-27 Reduced 2.85%	922 $36,000
Q4 2022 Feb 10, 2023	SELL	$33.72 - $46.33 $708 - $972	-21 Reduced 2.16%	949 $43,000
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $159 - $264	4 Added 0.41%	970 $40,000
Q2 2022 Aug 12, 2022	SELL	$45.8 - $85.4 $5,862 - $10,931	-128 Reduced 11.7%	966 $58,000
Q1 2022 May 13, 2022	SELL	$62.2 - $84.4 $311 - $422	-5 Reduced 0.45%	1,094 $79,000
Q4 2021 Feb 11, 2022	SELL	$73.71 - $87.86 $1,916 - $2,284	-26 Reduced 2.31%	1,099 $92,000
Q3 2021 Nov 12, 2021	SELL	$77.92 - $102.4 $7,324 - $9,625	-94 Reduced 7.71%	1,125 $101,000
Q2 2021 Aug 13, 2021	SELL	$92.19 - $115.71 $3.47 Million - $4.35 Million	-37,602 Reduced 96.86%	1,219 $116,000
Q1 2021 May 07, 2021	BUY	$106.9 - $167.73 $45,646 - $71,620	427 Added 1.11%	38,821 $4.42 Million
Q4 2020 Feb 12, 2021	BUY	$84.4 - $177.39 $337,515 - $709,382	3,999 Added 11.63%	38,394 $5.32 Million
Q3 2020 Nov 04, 2020	SELL	$72.98 - $90.0 $21,456 - $26,460	-294 Reduced 0.85%	34,395 $2.83 Million
Q2 2020 Aug 12, 2020	BUY	$46.91 - $78.22 $109,769 - $183,034	2,340 Added 7.23%	34,689 $2.71 Million
Q1 2020 May 04, 2020	SELL	$33.8 - $62.9 $63,205 - $117,623	-1,870 Reduced 5.46%	32,349 $1.44 Million
Q4 2019 Feb 05, 2020	SELL	$36.08 - $45.83 $10,391 - $13,199	-288 Reduced 0.83%	34,219 $1.46 Million
Q3 2019 Nov 08, 2019	SELL	$42.5 - $63.11 $10,200 - $15,146	-240 Reduced 0.69%	34,507 $1.48 Million
Q2 2019 Aug 13, 2019	BUY	$54.93 - $74.36 $67,179 - $90,942	1,223 Added 3.65%	34,747 $2.21 Million
Q1 2019 May 06, 2019	BUY	$39.87 - $69.36 $82,451 - $143,436	2,068 Added 6.57%	33,524 $2.33 Million
Q4 2018 Feb 13, 2019	BUY	$38.89 - $77.3 $10,305 - $20,484	265 Added 0.85%	31,456 $1.37 Million
Q3 2018 Nov 09, 2018	BUY	$71.81 - $90.15 $40,285 - $50,574	561 Added 1.83%	31,191 $2.38 Million
Q2 2018 Aug 08, 2018	BUY	$48.54 - $85.31 $104,215 - $183,160	2,147 Added 7.54%	30,630 $2.36 Million
Q1 2018 May 07, 2018	BUY	$44.33 - $58.52 $80,680 - $106,506	1,820 Added 6.83%	28,483 $1.45 Million
Q4 2017 Feb 09, 2018	BUY	$43.54 - $57.32 $5,486 - $7,222	126 Added 0.47%	26,663 $1.24 Million
Q3 2017 Nov 09, 2017	BUY	$49.79 - $66.32 $1.32 Million - $1.76 Million	26,537	26,537 $1.41 Million

Others Institutions Holding RARE

# of Institutions

287

Shares Held

88.1M

Call Options Held

505K

Put Options Held

198K

Vanguard Group Inc Valley Forge, PA

9.78M
Shares

$543 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.6M
Shares

$311 Million
0.01% of portfolio
Sands Capital Management, LLC Arlington, VA

5.35M
Shares

$297 Million
0.68% of portfolio
Wellington Management Group LLP Boston, MA

4.56M
Shares

$253 Million
0.03% of portfolio
Rtw Investments, LP New York, NY

3.26M
Shares

$181 Million
2.24% of portfolio

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.89B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account